about
IFN-γ production to leishmania antigen supplements the leishmania skin test in identifying exposure to L. braziliensis infectionIntranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB/c mice against infectionImmunologic response and memory T cells in subjects cured of tegumentary leishmaniasis.Reduced pathology following infection with transgenic Leishmania major expressing murine CD40 ligand.Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against LeishmaniaImmunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathologyCutaneous Leishmania infection: progress in pathogenesis research and experimental therapy.Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example.Anti-leishmanial effects of trinitroglycerin in BALB/C mice infected with Leishmania major via nitric oxide pathway.Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process.Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.Previous exposure to a low infectious dose of Leishmania major exacerbates infection with Leishmania infantum in the susceptible BALB/c mouse.Caffeic acid combined with autoclaved Leishmania major boosted the protection of infected BALB/c mice by enhancing IgG2 production, IFN-γ/TGF-β and iNO synthase/arginase1 ratios, and the death of infected phagocytes.CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after Leishmania infantum Infection.
P2860
Q34535297-B6057138-063E-42C3-986C-82FC7AA20010Q34667457-3223086C-AA02-4378-9B0D-271FE0CC3AD7Q35037274-C1DD4447-9D9C-441B-A72D-1EF00BEF5B1AQ35913436-3FC72932-B6A4-46EB-8FF8-2E25784D6AFAQ36251325-2E9FBAC7-A275-49A4-B02C-685C322A2FD3Q36617322-D7469ED0-BDC5-4652-A0AD-004C52153BF2Q36759574-7FED6080-E7A8-4122-8E73-338AF13316DEQ37118101-4DCD1A79-57C0-4A61-AFD4-85D89BA4AC96Q37208373-40234409-D414-48D1-8498-FD273A937AC0Q37310681-1D9E4EC7-2F06-4ED4-AFE6-3961737258E4Q41383476-381805FF-36CF-45DF-8BB6-395593A19061Q44218777-09067832-A373-474E-9D66-D9090C7D2BBBQ46878999-F39AC3CC-52B1-4635-AF2D-A06C6642CCE0Q49562362-72633B11-0CA4-41B9-ACE2-CCD68B615915
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Immunologic memory in cutaneous leishmaniasis.
@ast
Immunologic memory in cutaneous leishmaniasis.
@en
type
label
Immunologic memory in cutaneous leishmaniasis.
@ast
Immunologic memory in cutaneous leishmaniasis.
@en
prefLabel
Immunologic memory in cutaneous leishmaniasis.
@ast
Immunologic memory in cutaneous leishmaniasis.
@en
P2860
P1476
Immunologic memory in cutaneous leishmaniasis.
@en
P2093
Phillip Scott
P2860
P304
P356
10.1111/J.1462-5822.2005.00626.X
P577
2005-12-01T00:00:00Z